EpiPen maker gave cash to lawmakers probing its high cost
Embattled drugmaker Mylan, which on Monday announced a cheaper, generic version of the EpiPen, has been funneling cash to lawmakers who are weighing whether to launch hearings into its sky-high prices, The Post has learned.
Sen. Charles Schumer (D-NY) has landed $10,000 in combined campaign contributions from Mylan CEO Heather Bresch and the company’s political action committee, all of which came in June, according to filings with the Federal Election Commission.
The revelation came Monday as the House Committee on Oversight and Government Reform launched a probe into the drug manufacturer.
It has also asked company officials to appear for a private briefing by Sept. 6 — just six days before the paperwork is due. A congressional hearing could be next. – READ MORE